Tools · Public company · Nashville, TN, US
Insight Molecular Diagnostics Inc.
Ticker IMDX · SEC CIK 0001642380
Track this companyFree. Adds Insight Molecular Diagnostics Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials32 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline3
- AdjuvantCarcinoma, Non-Small-Cell LungClinicalTrials.gov · fetched Nov 12, 2026
- donor-derived cell-free DNA testKidney Transplant RejectionClinicalTrials.gov · fetched Nov 12, 2026
- ObservationCarcinoma, Non-Small-Cell LungClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- GraftAssure Lowering Allograft rejeCTIon by Combination- (GALACTIC) TrialNOT_YET_RECRUITING · started Jun 1, 2026ClinicalTrials.gov NCT07551531 · fetched Nov 12, 2026
- Validation of Donor-Derived Cell-Free DNA (Dd-cfDNA) for Kidney Transplant MonitoringRECRUITING · started Sep 8, 2025ClinicalTrials.gov NCT07060716 · fetched Nov 12, 2026
- Predictive Assay for Decision Making in Adjuvant TherapyTERMINATED · started Jan 28, 2022ClinicalTrials.gov NCT05032352 · fetched Nov 12, 2026
SEC filings12
- 8-K · 8-KSEC EDGAR · filed Sep 21, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 10, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 10, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 17, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 13, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 13, 2026 · fetched Nov 12, 2026
- 8-K/A · 8-K/ASEC EDGAR · filed May 13, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Apr 30, 2026 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Mar 26, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 26, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Feb 26, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Feb 12, 2026 · fetched Nov 12, 2026